Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  European Journal of Clinical Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 12743668
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction.

  2000cited by this paper
• Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction.

  1999cited by this paper
• Tumor necrosis factor in the heart.

  1998cited by this paper
• Intravenous adenosine and lidocaine in patients with acute myocardial infarction.

  1998cited by this paper
• Characterization of a transient outward K+ current with inward rectification in canine ventricular myocytes.

  1998cited by this paper
• Progression of myocardial necrosis during reperfusion of ischemic myocardium.

  1998cited by this paper
• Preconditioning of human myocardium with adenosine during coronary angioplasty.

  1997cited by this paper
• A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.

  1995cited by this paper
• Effect of adenosine on myocardial 'stunning' in the dog.

  1995cited by this paper
• Reperfusion injury induces apoptosis in rabbit cardiomyocytes.

  1994cited by this paper
• Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group.

  1994cited by this paper
• Adenosine, an endogenous anti-inflammatory agent.

  1994cited by this paper
• Selection of the Optimal Nonexercise Stress for the Evaluation of Ischemic Regional Myocardial Dysfunction and Malperfusion Comparison of Dobutamine and Adenosine Using Echocardiography and 99mTc‐MIBI Single Photon Emission Computed Tomography

  1993cited by this paper
• Time Course of Functional Improvement in Stunned Myocardium in Risk Area in Patients With Reperfused Anterior Infarction

  1993cited by this paper
• The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.

  1993cited by this paper
• Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge.

  1993cited by this paper
• The effects of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonists on myocardial reperfusion injury.

  1992cited by this paper
• Effect of intravenous adenosine on myocardial reperfusion injury in a model with low myocardial collateral blood flow.

  1991cited by this paper
• Cardiac Electrophysiology of Adenosine: Basic and Clinical Concepts

  1991cited by this paper
• Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period.

  1991cited by this paper
• Combined adenosine and lidocaine administration limits myocardial reperfusion injury.

  1990cited by this paper
• Mechanism of Myocardial “Stunning”

  1990cited by this paper
• Intracoronary adenosine administration during reperfusion following 3 hours of ischemia: effects on infarct size, ventricular function, and regional myocardial blood flow.

  1990cited by this paper
• Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

  1989cited by this paper
• Attenuation of no-reflow phenomenon, neutrophil activation, and reperfusion injury in intestinal microcirculation by topical adenosine.

  1989cited by this paper
• Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: influence of infarct location on arterial patency, left ventricular function and mortality.

  1989cited by this paper
• Transesophageal echocardiography.

  1989cited by this paper
• Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon.

  1987cited by this paper
• Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.

  1986cited by this paper
• Adenosine: a physiological modulator of superoxide anion generation by human neutrophils

  1983cited by this paper
• Abnormal myocardial fluid retention as an early manifestation of ischemic injury.

  1977cited by this paper

• Synthetic Small-Molecule Ligands Targeted to Adenosine Receptors: Is There Potential Towards Ischemic Heart Disease?

  2025cites this paper
• Pharmacological and Interventional Prevention and Treatment of Microvascular Obstruction Following Primary PCI in STEMI

  2025cites this paper
• Hydrogel delivery of purinergic enzymes improves cardiac ischemia/reperfusion injury.

  2023cites this paper
• Endless Journey of Adenosine Signaling in Cardioprotective Mechanism of Conditioning Techniques: Clinical Evidence

  2023cites this paper
• Adenosine in Acute Myocardial Infarction-Associated Reperfusion Injury: Does it Still Have a Role?

  2022cites this paper
• Adenosine as adjunctive therapy in acute coronary syndrome: a meta-analysis of randomized controlled trials.

  2022cites this paper
• The Hypoxia-Adenosine Link during Myocardial Ischemia—Reperfusion Injury

  2022cites this paper
• Targeted pharmacotherapy for ischemia reperfusion injury in acute myocardial infarction

  2020cites this paper
• Adenosine and Its Receptors: An Expected Tool for the Diagnosis and Treatment of Coronary Artery and Ischemic Heart Diseases

  2020cites this paper
• Adenosine and the Cardiovascular System

  2019cites this paper
• Adenosine as cardioprotective in off-pump coronary artery bypass grafting

  2019cites this paper
• Design and Rationale for comParison Between ticagreLor and clopidogrEl on mIcrocirculation in Patients with Acute cOronary Syndrome Undergoing Percutaneous Coronary Intervention (PLEIO) Trial

  2018cites this paper
• Targeting mitochondrial permeability as a pharmacological cardioprotective strategy.

  2017cites this paper
• A Randomized Controlled Trial of Intra-Aortic Adenosine Infusion Before Release of the Aortic Cross-Clamp During Coronary Artery Bypass Surgery.

  2017cites this paper
• Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: An updated meta-analysis of randomized controlled trials

  2016cites this paper
• The REFLO-STEMI (REperfusion Facilitated by LOcal adjunctive therapy in ST-Elevation Myocardial Infarction) trial: a randomised controlled trial comparing intracoronary administration of adenosine or sodium nitroprusside with control for attenuation of microvascular obstruction during primary percut

  2016cites this paper
• P Coronary Artery Disease Randomized , Double-Blinded , lacebo-Controlled Multicenter Trial f Adenosine as an Adjunct to Reperfusion in the reatment of Acute Myocardial Infarction ( AMISTAD-II )

  2016cites this paper
• Percutaneous Coronary Interventions in Stable and Acute Coronary Syndromes: Stent technology, lesion complexity and clinical outcome

  2015cites this paper
• The no-reflow phenomenon: State of the art.

  2015cites this paper
• Adenosine as an Adjunct Therapy in ST Elevation Myocardial Infarction Patients: Myth or Truth?

  2015cites this paper
• Ischemia-Reperfusion Injury of the Heart: Moving forward with our Knowledge

  2015cites this paper
• Efficacy of Adenosine in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

  2015influential citation
• Pharmacological approaches to coronary microvascular dysfunction.

  2014cites this paper
• The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised controlled trial

  2014cites this paper
• Role of adenosine as an adjunct therapy in the prevention and treatment of no-reflow phenomenon in acute myocardial infarction with ST segment elevation: review of the current data.

  2013cites this paper
• Effect of New Method of Intracoronary Adenosine Injection during Primary Percutaneous Coronary Intervention on Microvascular Reperfusion Injury - Clinical Outcome and 1-Year Follow-Up

  2013cites this paper
• Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection.

  2013cites this paper
• Therapy against ischemic injury.

  2013cites this paper
• Myocardial 'no-reflow' prevention.

  2013cites this paper
• Zjawiska slow-flow, no-reflow, dystalna embolizacja — klasyfikacja, rokowanie i możliwości zapobiegania

  2013cites this paper
• Three hours continuous injection of adenosine improved left ventricular function and infarct size in patients with ST-segment elevation myocardial infarction.

  2012cites this paper
• Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials

  2012cites this paper
• Pharmacological cardiac protection

  2012cites this paper
• Επίδραση της χορήγησης αντιαιμοπεταλιακών φαρμάκων στη θρόμβωση και τη φλεγμονή σε ασθενείς με οξύ στεφανιαίο σύνδρομο

  2012cites this paper
• Targeting reperfusion injury in acute myocardial infarction: a review of reperfusion injury pharmacotherapy

  2012cites this paper
• Comparison of the Effects of Adenosine, Inosine, and Their Combination as an Adjunct to Reperfusion in the Treatment of Acute Myocardial Infarction

  2012cites this paper
• Adenosine improves post-procedural coronary flow but not clinical outcomes in patients with acute coronary syndrome: a meta-analysis of randomized trials.

  2012cites this paper
• Novel P2Y12 Receptor Antagonists - Prasugrel and Ticagrelor. Systematic Review, Indirect Comparison to Clopidogrel in Cardiovascular Disease, Design of a Randomized Controlled Trial

  2011influential citation
• Adenosine release: a potential explanation for the benefits of ticagrelor in the PLATelet inhibition and clinical outcomes trial?

  2011cites this paper
• denosine improves post-procedural coronary flow but not clinical outcomes in atients with acute coronary syndrome : A meta-analysis of randomized trials

  2011cites this paper
• New method of intracoronary adenosine injection to prevent microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention.

  2011cites this paper
• Synergy between pharmacological and mechanical reperfusion in ST-segment elevation myocardial infarction patients: 2011 update

  2011cites this paper
• Conditioning of the heart: from pharmacological interventions to local and remote protection: possible implications for clinical practice.

  2011cites this paper
• Left Ventricular Diastolic Dysfunction by Tissue Doppler Imaging in Acute Myocardial Infarction

  2010cites this paper
• Lipoxygenase-derived eicosanoids in myocardial ischaemia-reperfusion injury: the role of sensory C-fibres and TRPV1

  2010cites this paper
• Prevention and treatment of no-reflow

  2010cites this paper
• The reduction of infarct size--forty years of research--second of two parts.

  2010cites this paper
• Cardioprotection With Adenosine-Regulating Agent, GP531: Effects on No-Reflow, Infarct Size, and Blood Flow Following Ischemia/ Reperfusion in the Rabbit

  2010cites this paper
• Reperfusion Injury, Microvascular Dysfunction, and Cardioprotection: The “Dark Side” of Reperfusion

  2009cites this paper
• Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol

  2009cites this paper
• Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection.

  2009cites this paper
• The ischemic preconditioning effect of adenosine in patients with ischemic heart disease

  2009cites this paper
• Preconditioning effects of adenosine in patients with severe coronary artery disease but preserved coronary flow reserve

  2009cites this paper
• Making the heart resistant to infarction: how can we further decrease infarct size?

  2008cites this paper
• Inhibitory reperfuzyjnego uszkodzenia mięśnia sercowego - kolejny milowy krok w leczeniu ostrych zespołów wieńcowych?

  2008cites this paper
• Angioplasty Strategies in ST-Segment–Elevation Myocardial Infarction: Part II: Intervention After Fibrinolytic Therapy, Integrated Treatment Recommendations, and Future Directions

  2008cites this paper
• Reperfusion injury in acute myocardial infarction: from bench to cath lab. Part II: Clinical issues and therapeutic options.

  2008cites this paper
• Intracoronary adenosine improves myocardial perfusion in late reperfused myocardial infarction.

  2008cites this paper
• Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies.

  2007cites this paper
• ANALGETIC AND ALGETIC EFFECTS OF ADENOSINE IN HEALTHY VOLUNTEERS AND PATIENTS WITH CORONARY ARTERY DISEASE

  2007cites this paper
• Adenosine as a Non-Opioid Analgesic in the Perioperative Setting

  2007cites this paper
• Reperfusion injury as a therapeutic challenge in patients with acute myocardial infarction

  2007cites this paper
• Biochemical basis of ischemic heart injury and of cardioprotective interventions.

  2007cites this paper
• Postconditioning the human heart with adenosine in heart valve replacement surgery.

  2007cites this paper
• High dose adenosine for suboptimal myocardial reperfusion after primary PCI: A randomized placebo‐controlled pilot study

  2007cites this paper
• Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection

  2007cites this paper
• Preconditioning, postconditioning and their application to clinical cardiology.

  2006cites this paper
• A review of the clinical use of anti-inflammatory therapies for reperfusion injury in myocardial infarction and stroke: where do we go from here?

  2006cites this paper
• Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial.

  2006cites this paper
• Different Effects of Adenosine and Calcium Channel Blockade on Myocardial No-Reflow after Acute Myocardial Infarction and Reperfusion

  2006cites this paper
• Prognostic importance of diastolic function and filling pressure in patients with acute myocardial infarction.

  2006cites this paper
• Symbols within words: have we neglected the AdeNOsine A2 receptor?

  2005cites this paper
• Adenosine-mediated cardioprotection in the aging myocardium.

  2005cites this paper
• Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process.

  2005cites this paper
• A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II).

  2005cites this paper
• Mechanisms, management and future directions for reperfusion injury after acute myocardial infarction

  2005cites this paper
• Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting.

  2005cites this paper
• Is left ventricular diastolic function an independent marker of prognosis after acute myocardial infarction?

  2004cites this paper
• Pharmacological Prevention of Reperfusion Injury in Acute Myocardial Infarction

  2004cites this paper
• Cardiac protection during acute myocardial infarction: where do we stand in 2004?

  2004cites this paper